Clinical Diversity, Risk Determinants, and Treatment Efficacy of Pediatric Arrhythmias
Overview
This study investigates pediatric arrhythmias in Xinjiang, identifying risk factors and treatment outcomes. Key findings include a high prevalence of supraventricular arrhythmias and specific independent risk factors such as congenital heart disease and recent infections.
Background
Pediatric arrhythmias are diverse and differ significantly from adult presentations, necessitating tailored management approaches. Understanding the clinical characteristics and risk factors in underreported regions like Xinjiang is crucial for improving diagnosis and treatment. This study addresses the gap in knowledge regarding pediatric arrhythmias in resource-variable settings.
Data Highlights
Characteristic
Value
Number of children with arrhythmia
232
Male percentage
50.9%
Age range
1.2–18.0 years
Common arrhythmia type
Supraventricular (49.1%)
PSVT percentage
35.3%
Ablation success rate
100% acute success
Overall response rate
88.2%
Key Findings
Supraventricular arrhythmias were the most common, accounting for 49.1% of cases.
PSVT represented 35.3% of the arrhythmias observed.
Independent risk factors included congenital heart disease (OR 7.265), recent infection exposure (OR 6.452), and recurrent arrhythmia history (OR 8.216).
Ablation was performed in 9.5% of cases, with 100% acute success in PSVT patients.
The overall response rate to treatment was 88.2%, with four mild adverse drug reactions reported.
Clinical Implications
The findings highlight the need for targeted ECG screening for high-risk pediatric populations. Additionally, maintaining school-based screening programs can aid in the early detection of subclinical arrhythmias.
Conclusion
This study provides valuable insights into the clinical landscape of pediatric arrhythmias in Xinjiang, emphasizing the need for region-specific management strategies and resource allocation.
Damon B. Dixon, MD, at Phoenix Children’s Cardiology, is the author to this EndoText chapter. Dr. Dixon brings nationally recognized expertise in pediatric cardiovascular risk assessment and non?invasive vascular imaging.
